Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) Director Sells $2,070,000.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Director Rodney Windley sold 180,000 shares of the business’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $2,070,000.00. Following the transaction, the director directly owned 2,078,017 shares of the company’s stock, valued at $23,897,195.50. This trade represents a 7.97% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Aveanna Healthcare Price Performance

NASDAQ:AVAH traded up $0.54 during trading hours on Monday, hitting $13.70. The company’s stock had a trading volume of 5,364,375 shares, compared to its average volume of 1,804,109. The stock has a fifty day simple moving average of $9.58 and a 200-day simple moving average of $7.92. The company has a market capitalization of $2.99 billion, a P/E ratio of 11.14, a PEG ratio of 0.92 and a beta of 1.90. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16. Aveanna Healthcare Holdings Inc. has a twelve month low of $5.93 and a twelve month high of $13.98.

Aveanna Healthcare (NASDAQ:AVAH) last issued its earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%.The firm had revenue of $670.48 million during the quarter, compared to the consensus estimate of $638.61 million. On average, analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.68 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of AVAH. BlackRock Inc. bought a new stake in shares of Aveanna Healthcare in the 2nd quarter valued at about $63,504,000. Vanguard Group Inc. lifted its stake in shares of Aveanna Healthcare by 38.0% in the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after acquiring an additional 1,535,351 shares during the period. Braidwell LP boosted its holdings in Aveanna Healthcare by 39.1% in the second quarter. Braidwell LP now owns 3,065,106 shares of the company’s stock valued at $26,268,000 after acquiring an additional 861,600 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Aveanna Healthcare by 17.7% in the fourth quarter. Geode Capital Management LLC now owns 1,849,057 shares of the company’s stock valued at $15,110,000 after acquiring an additional 278,429 shares during the last quarter. Finally, Nuveen LLC increased its position in Aveanna Healthcare by 135.9% during the 4th quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock valued at $12,838,000 after purchasing an additional 905,316 shares during the period. 87.96% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

AVAH has been the topic of a number of research analyst reports. BMO Capital Markets raised their target price on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Royal Bank Of Canada increased their price target on Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a research note on Monday. Wall Street Zen downgraded Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Barclays boosted their price objective on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a research report on Thursday, July 9th. Finally, Truist Financial increased their target price on Aveanna Healthcare from $11.00 to $15.00 and gave the company a “hold” rating in a research report on Monday. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $12.89.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.